FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280511027> ?p ?o ?g. }

• W4280511027 endingPage "863" @default.
• W4280511027 startingPage "855" @default.
• W4280511027 abstract "Antiphospholipid syndrome (APS) affects the brain by both hypercoagulation and immunological mechanisms. APS is characterized by several autoantibodies binding to a thrombolytic complex including beta-2-glycoprotein I (β2-GPI) and annexin A2 (ANXA2). Teriflunomide, an oral drug for the treatment of multiple sclerosis (MS), has a cytostatic effect on B cells and is therefore a potential antibody-targeting treatment for APS. In this study, we assessed the effect of teriflunomide in two APS mouse models by inducing autoantibody formation against β2-GPI and ANXA2 in female BALB/c mice. The ANXA2 model displayed a behavioral change suggesting an anti-anxiety effect in open field and forced swim tests, early in the course of the disease. This effect was normalized following teriflunomide treatment. Conversely, behavioral tests done later during the study demonstrated depression-like behavior in the ANXA2 model. No behavioral changes were seen in the β2-GPI model. Total brain IgG levels were significantly elevated in the ANXA2 model but not in the teriflunomide treated group. No such change was noted in the brains of the β2-GPI model. High levels of serum autoantibodies were induced in both models, and their levels were not lowered by teriflunomide treatment. Teriflunomide ameliorated behavioral changes in mice immunized with ANXA2 without a concomitant change in serum antibody levels. These findings are compatible with the effect of teriflunomide on neuroinflammation.Teriflunomide ameliorated behavioral and brain IgG levels in mice immunized with ANXA2 without a concomitant change in serum antibody levels. These findings are compatible with an effect of teriflunomide on the IgG permeability to the brain and neuroinflammation." @default.
• W4280511027 created "2022-05-22" @default.
• W4280511027 creator A5005960223 @default.
• W4280511027 creator A5006499979 @default.
• W4280511027 creator A5053156520 @default.
• W4280511027 creator A5072166912 @default.
• W4280511027 creator A5074352989 @default.
• W4280511027 creator A5081974486 @default.
• W4280511027 date "2022-05-16" @default.
• W4280511027 modified "2023-10-16" @default.
• W4280511027 title "Teriflunomide normalizes anti-anxiety effect in anti-ANXA2 APS mice model teriflunomide in anti-ANXA2 mice model" @default.
• W4280511027 cites W1553348996 @default.
• W4280511027 cites W1851052710 @default.
• W4280511027 cites W1983382084 @default.
• W4280511027 cites W1999480517 @default.
• W4280511027 cites W2013474514 @default.
• W4280511027 cites W2032318569 @default.
• W4280511027 cites W2045574667 @default.
• W4280511027 cites W2054330426 @default.
• W4280511027 cites W2054495051 @default.
• W4280511027 cites W2057146931 @default.
• W4280511027 cites W2070162478 @default.
• W4280511027 cites W2070863059 @default.
• W4280511027 cites W2074160967 @default.
• W4280511027 cites W2092297430 @default.
• W4280511027 cites W2099005866 @default.
• W4280511027 cites W2101108802 @default.
• W4280511027 cites W2108797827 @default.
• W4280511027 cites W2109814589 @default.
• W4280511027 cites W2131578833 @default.
• W4280511027 cites W2140483523 @default.
• W4280511027 cites W2141197159 @default.
• W4280511027 cites W2156364422 @default.
• W4280511027 cites W2167731608 @default.
• W4280511027 cites W2170654913 @default.
• W4280511027 cites W2314385198 @default.
• W4280511027 cites W2345539971 @default.
• W4280511027 cites W2474144199 @default.
• W4280511027 cites W2479868259 @default.
• W4280511027 cites W2495465436 @default.
• W4280511027 cites W2521080866 @default.
• W4280511027 cites W2566760920 @default.
• W4280511027 cites W2767895591 @default.
• W4280511027 cites W2799578891 @default.
• W4280511027 cites W2809915807 @default.
• W4280511027 cites W2874472082 @default.
• W4280511027 cites W2894608536 @default.
• W4280511027 cites W2899690662 @default.
• W4280511027 cites W2948862715 @default.
• W4280511027 cites W2993559076 @default.
• W4280511027 cites W2997815644 @default.
• W4280511027 doi "https://doi.org/10.1177/09612033221095150" @default.
• W4280511027 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35575144" @default.
• W4280511027 hasPublicationYear "2022" @default.
• W4280511027 type Work @default.
• W4280511027 citedByCount "0" @default.
• W4280511027 crossrefType "journal-article" @default.
• W4280511027 hasAuthorship W4280511027A5005960223 @default.
• W4280511027 hasAuthorship W4280511027A5006499979 @default.
• W4280511027 hasAuthorship W4280511027A5053156520 @default.
• W4280511027 hasAuthorship W4280511027A5072166912 @default.
• W4280511027 hasAuthorship W4280511027A5074352989 @default.
• W4280511027 hasAuthorship W4280511027A5081974486 @default.
• W4280511027 hasConcept C126322002 @default.
• W4280511027 hasConcept C159654299 @default.
• W4280511027 hasConcept C163764329 @default.
• W4280511027 hasConcept C203014093 @default.
• W4280511027 hasConcept C2776036978 @default.
• W4280511027 hasConcept C2776912625 @default.
• W4280511027 hasConcept C2776914184 @default.
• W4280511027 hasConcept C2777703276 @default.
• W4280511027 hasConcept C2779134260 @default.
• W4280511027 hasConcept C2779384505 @default.
• W4280511027 hasConcept C2780022809 @default.
• W4280511027 hasConcept C2780640218 @default.
• W4280511027 hasConcept C71924100 @default.
• W4280511027 hasConcept C87753298 @default.
• W4280511027 hasConcept C98274493 @default.
• W4280511027 hasConceptScore W4280511027C126322002 @default.
• W4280511027 hasConceptScore W4280511027C159654299 @default.
• W4280511027 hasConceptScore W4280511027C163764329 @default.
• W4280511027 hasConceptScore W4280511027C203014093 @default.
• W4280511027 hasConceptScore W4280511027C2776036978 @default.
• W4280511027 hasConceptScore W4280511027C2776912625 @default.
• W4280511027 hasConceptScore W4280511027C2776914184 @default.
• W4280511027 hasConceptScore W4280511027C2777703276 @default.
• W4280511027 hasConceptScore W4280511027C2779134260 @default.
• W4280511027 hasConceptScore W4280511027C2779384505 @default.
• W4280511027 hasConceptScore W4280511027C2780022809 @default.
• W4280511027 hasConceptScore W4280511027C2780640218 @default.
• W4280511027 hasConceptScore W4280511027C71924100 @default.
• W4280511027 hasConceptScore W4280511027C87753298 @default.
• W4280511027 hasConceptScore W4280511027C98274493 @default.
• W4280511027 hasIssue "7" @default.
• W4280511027 hasLocation W42805110271 @default.
• W4280511027 hasLocation W42805110272 @default.
• W4280511027 hasOpenAccess W4280511027 @default.
• W4280511027 hasPrimaryLocation W42805110271 @default.

• next